companydata.dkcompanydata.dk

BIOPORTO DIAGNOSTICS A/S: Financial statements 2021

CVR: 18645882

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 24,253,658 and a net result of DKK -54,122,850 compared with DKK -42,627,971 the year before. That is an increase of 4.5% compared with the year before. The profit margin was -223.2%. Equity in the 2021 report amounted to DKK -458,748,978. The company had 15 employees in the financial year.

Revenue
DKK 24,253,658
Gross Profit
DKK -15,175,202
Profit/Loss
DKK -54,122,850
Equity
DKK -458,748,978
Total Assets
DKK 22,984,731
Employees
15

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202124.3M-15.2M-54.1M-458.7M15
202023.2M-10.6M-42.6M-404.6M16
201926.6M-6.9M-67.3M-362M17
201825.9M-417K-43.7M-294.7M17
201726M-2.9M-35.3M-251M16

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like BIOPORTO DIAGNOSTICS A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

BIOPORTO DIAGNOSTICS A/S: The 2020 annual report is outJun 30, 2021

BIOPORTO DIAGNOSTICS A/S has published its annual report for 2020. Revenue came to DKK 23,203,609, and the net result was DKK -42,627,971.

Henrik Clausen joins the board of BIOPORTO DIAGNOSTICS A/SJun 17, 2021

As of June 17, 2021, Henrik Clausen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.

Torben Arnth Nielsen leaves the board of BIOPORTO DIAGNOSTICS A/SJun 17, 2021

As of June 17, 2021, Torben Arnth Nielsen has left the board of directors of BIOPORTO DIAGNOSTICS A/S.

Ole Larsen leaves the board of BIOPORTO DIAGNOSTICS A/SJun 17, 2021

As of June 17, 2021, Ole Larsen has left the board of directors of BIOPORTO DIAGNOSTICS A/S.

About BIOPORTO DIAGNOSTICS A/S

BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 28 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.

Source: annual report 2025, Danish Business Authority